Insmed Incorporated
INSM
$116.00
$12.1111.66%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 50.21% | 11.23% | -15.03% | -25.37% | -8.93% |
| Total Depreciation and Amortization | -10.86% | 45.25% | 7.75% | 22.97% | 18.35% |
| Total Amortization of Deferred Charges | 0.23% | 1.29% | -11.56% | -4.78% | 2.50% |
| Total Other Non-Cash Items | -101.84% | -14.91% | 29.73% | 82.89% | 774.82% |
| Change in Net Operating Assets | -70.58% | -370.89% | 45.69% | 114.43% | -335.01% |
| Cash from Operations | 10.04% | -12.67% | -6.90% | 21.56% | -33.73% |
| Capital Expenditure | 79.02% | -586.06% | 30.60% | 65.40% | -48.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -33.74% | 153.43% | -428.47% | 155.65% | -34.68% |
| Cash from Investing | -31.81% | 151.09% | -434.55% | 183.33% | -38.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.96% | -3.88% | 72.30% | -282.01% | -2.92% |
| Issuance of Common Stock | -12.48% | 1.40% | -96.03% | 2,796.93% | 116.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.83% | 1.34% | -96.11% | 2,858.16% | -81.80% |
| Foreign Exchange rate Adjustments | -8,000.00% | 100.72% | -197.11% | 12.29% | 159.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -59.16% | 118.50% | -207.77% | 680.48% | -262.20% |